133 related articles for article (PubMed ID: 35928927)
1. TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for Colorectal Cancer.
Hao T; Yu H; Huang D; Liu Q
Dis Markers; 2022; 2022():5884531. PubMed ID: 35928927
[TBL] [Abstract][Full Text] [Related]
2. TMUB1 expression is associated with the prognosis of colon cancer and immune cell infiltration.
Lu Y; Wang K; Peng Y; Zhang J; Ju Q; Xu Q; Ouyang M; He Z
PeerJ; 2023; 11():e16334. PubMed ID: 38025742
[TBL] [Abstract][Full Text] [Related]
3. Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer.
Shang Y; Zhang Y; Liu J; Chen L; Yang X; Zhu Z; Li D; Deng Y; Zhou Z; Lu B; Fu CG
J Cancer; 2022; 13(2):653-668. PubMed ID: 35069909
[TBL] [Abstract][Full Text] [Related]
4. Transmembrane and Ubiquitin-Like Domain Containing 1 Protein (TMUB1) Negatively Regulates Hepatocellular Carcinoma Proliferation via Regulating Signal Transducer and Activator of Transcription 1 (STAT1).
Chen Y; Fu H; Zhang Y; Chen P
Med Sci Monit; 2019 Dec; 25():9471-9482. PubMed ID: 31827061
[TBL] [Abstract][Full Text] [Related]
5. GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.
Nambara S; Masuda T; Kobayashi Y; Sato K; Tobo T; Koike K; Noda M; Ogawa Y; Kuroda Y; Ito S; Eguchi H; Sugimachi K; Mimori K
Cancer Sci; 2020 Feb; 111(2):343-355. PubMed ID: 31758608
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane and Ubiquitin-Like Domain-Containing 1 Promotes Glioma Growth and Indicates Unfavorable Prognosis.
Liu Y; Cai C; Wu K; Hu L
Int J Genomics; 2023; 2023():3318171. PubMed ID: 38148953
[TBL] [Abstract][Full Text] [Related]
7. CCAAT/enhancer-binding protein β regulates interleukin-6-induced transmembrane and ubiquitin-like domain containing 1 gene expression in hepatocytes.
Liu M; Yuan T; Liu H; Chen P
Mol Med Rep; 2014 Oct; 10(4):2177-83. PubMed ID: 25109894
[TBL] [Abstract][Full Text] [Related]
8. Tmub1 negatively regulates liver regeneration via inhibiting STAT3 phosphorylation.
Fu H; Dong R; Zhang Y; Xu J; Liu M; Chen P
Cell Signal; 2019 Mar; 55():65-72. PubMed ID: 30610893
[TBL] [Abstract][Full Text] [Related]
9. Tmub1 Suppresses Hepatocellular Carcinoma by Promoting the Ubiquitination of ΔNp63 Isoforms.
Fu H; Zhang Y; Chen J; Zhou B; Chen G; Chen P
Mol Ther Oncolytics; 2020 Sep; 18():126-136. PubMed ID: 32671188
[TBL] [Abstract][Full Text] [Related]
10. MiR-27a/b Regulates Liver Regeneration by Posttranscriptional Modification of Tmub1.
Lan X; Li G; Liu H; Fu H; Chen P; Liu M
Dig Dis Sci; 2018 Sep; 63(9):2362-2372. PubMed ID: 29777440
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis reveals Tmub1 as a cell cycle-associated protein in rat hepatocytes.
Fu H; Xu J; Chen J; Li G; Zhao X; Chen P
Mol Med Rep; 2018 Mar; 17(3):4337-4344. PubMed ID: 29344642
[TBL] [Abstract][Full Text] [Related]
12. Nicotine-derived NNK promotes CRC progression through activating TMUB1/AKT pathway in METTL14/YTHDF2-mediated m6A manner.
Jiang M; Han J; Ma Q; Chen X; Xu R; Wang Q; Zheng J; Wang W; Song J; Huang Y; Chen Y
J Hazard Mater; 2024 Apr; 467():133692. PubMed ID: 38341886
[TBL] [Abstract][Full Text] [Related]
13. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
[TBL] [Abstract][Full Text] [Related]
14. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
Yuan J; Xie A; Cao Q; Li X; Chen J
Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer.
Lu C; Liao W; Huang Y; Huang Y; Luo Y
BMC Gastroenterol; 2022 Apr; 22(1):207. PubMed ID: 35473611
[TBL] [Abstract][Full Text] [Related]
16. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
[TBL] [Abstract][Full Text] [Related]
17. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
[No Abstract] [Full Text] [Related]
18. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
Zhang J; Liu W; Feng S; Zhong B
World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
[TBL] [Abstract][Full Text] [Related]
20. [METTL27 is a prognostic biomarker of colon cancer and associated with immune invasion].
Wang K; Zhang J; Deng M; Ju Y; Ouyang M
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):486-497. PubMed ID: 35527484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
